Roche to Buy German Cell Analysis Company | GenomeWeb

NEW YORK (GenomeWeb News) – Roche has reached an agreement with Innovatis to buy the cell analysis company for €15 million ($19.5 million), the Swiss life sciences firm said today.

Roche said that the acquisition of the Bielefeld, Germany-based company, which focuses on automated cell analysis solutions including cell counting, viability testing, and cell function, fits with its strategy to strengthen its cell research market offerings.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.